http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105106235-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate | 2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105106235-B |
| titleOfInvention | A kind of SODLUM FULVATE pharmaceutical composition, SODLUM FULVATE capsule preparations and preparation method thereof |
| abstract | The invention discloses a kind of SODLUM FULVATE pharmaceutical composition, SODLUM FULVATE capsule preparations and preparation method thereof.SODLUM FULVATE pharmaceutical composition provided by the invention, is grouped as by the group of following parts by weight: 2.8~11.1 parts of SODLUM FULVATE, 112.5~130 parts of pregelatinized starch, 75~88 parts of starch, 12~30 parts of microcrystalline cellulose, 4.2~40 parts of disintegrating agent.Present invention simultaneously provides with SODLUM FULVATE capsule preparations made of aforementioned pharmaceutical compositions; it is using pregelatinized starch, starch, micro cellulose as filler; using sodium carboxymethyl starch, dried starch as disintegrating agent; the dosage form keeps the absorption of SODLUM FULVATE drug more preferable; dissolution rate is more preferable; the gastric retention time is longer, not only increases the stability of drug while also having certain masking, protective effect to drug.The capsule preparations have the characteristics that simultaneously taking dose is small, compliance is good, easy storage and transportation, carry it is easy to use. |
| priorityDate | 2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.